Inventor · disambiguated record
Kohei Miyazono
Also filed as: MIYAZONO KOHEI
28 granted patents·7 pending applications·495 citations·filing 1990–2021
97Inventor score
Top patents by PatentIndex Score
35 records- 0190US6534476B2Smad6 and uses thereofJAPAN FOUND CANCER·Filed 2001·Granted Mar 18, 2003·39 cites·12 claims
- 0289US6692925B1Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their useLUDWIG INST CANCER RES·Filed 1999·Granted Feb 17, 2004·110 cites·7 claims
- 0387US5229495ASubstantially pure receptor like TGF-β 1 binding molecules and uses thereofLUDWIG INST CANCER RES·Filed 1991·Granted Jul 20, 1993·64 cites·5 claims
- 0484US7592428B1Antibodies which bind specifically to activin receptor like kinasesLUDWIG INST CANCER RES·Filed 2003·Granted Sep 22, 2009·7 cites·2 claims
- 0581US6331621B1Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing theseLUDWIG INST CANCER RES·Filed 2000·Granted Dec 18, 2001·10 cites·10 claims
- 0681US5280109AIsolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2LUDWIG INST CANCER RES·Filed 1992·Granted Jan 18, 1994·44 cites·3 claims
- 0778US5863738AMethods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptidesCREATIVE BIOMOLECULES INC·Filed 1995·Granted Jan 26, 1999·39 cites·3 claims
- 0876US7276525B2Osteogenesis-promotion enhancer and method of screening the sameNIPPON SHINYAKU CO LTD·Filed 2004·Granted Oct 2, 2007·8 cites·3 claims
- 0976US6982319B2Antibodies which bind specifically to activin receptor-like kinasesLUDWIG INST CANCER RES·Filed 2001·Granted Jan 3, 2006·6 cites·2 claims
- 1076US6316217B1Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding sameLUDWIG INST CANCER RES·Filed 1993·Granted Nov 13, 2001·21 cites·22 claims
- 1174US5346993AIsolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2LUDWIG INST CANCER RES·Filed 1993·Granted Sep 13, 1994·30 cites·4 claims
- 1272US8012704B2Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their useLUDWIG INST CANCER RES·Filed 2010·Granted Sep 6, 2011·1 cites·8 claims
- 1372US5731200AIsolated nucleic acid encoding receptor-like TGF-β1 binding proteinLUDWIG INST CANCER RES·Filed 1995·Granted Mar 24, 1998·18 cites·8 claims
- 1467US6207814B1Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding themLUDWIG INST CANCER RES·Filed 1999·Granted Mar 27, 2001·15 cites·5 claims
- 1564US7932351B2Activin receptor-like kinase-1 proteins having serine-threonine kinase domainsLUDWIG INST CANCER RES·Filed 2007·Granted Apr 26, 2011·0 cites·9 claims
- 1664US7067260B2Methods of identifying morphogen receptor-binding analogsCURIS INC·Filed 2001·Granted Jun 27, 2006·4 cites·20 claims
- 1760US8080639B2Antibodies which bind specifically to activin receptor like kinase 3MIYAZONO KOHEI·Filed 2007·Granted Dec 20, 2011·0 cites·4 claims
- 1859US2005048607A1Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their useFiled 2003·Application pending·0 cites
- 1958US5578703ASubstantially pure receptor like TFG-β1 binding moleculesLUDWIG INST CANCER RES·Filed 1992·Granted Nov 26, 1996·14 cites·2 claims
- 2057US7560532B2Smad6 and uses thereofJAPAN FOUND CANCER·Filed 2005·Granted Jul 14, 2009·0 cites·8 claims
- 2154US6271365B1Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding themLUDWIG INST CANCER RES·Filed 1999·Granted Aug 7, 2001·7 cites·26 claims
- 2254US6194187B1Apoptosis-inducing protein and gene encoding the sameJAPAN FOUND CANCER·Filed 1997·Granted Feb 27, 2001·10 cites·25 claims
- 2354US5227302ADNA encoding platelet derived endothelial cell growth factor (PD-ECGF)LUDWIG INST CANCER RES·Filed 1991·Granted Jul 13, 1993·18 cites·11 claims
- 2453US6964853B2Smad6 and uses thereofJAPAN FOUND CANCER·Filed 2003·Granted Nov 15, 2005·0 cites·5 claims
- 2553US2005233379A1Methods of antagonizing morphogensLUDWIG INST CANCER RES·Filed 2005·Application pending·0 cites
- 2653US2012258042A1Combined use of tgf-b signaling inhibitor and antitumor agentKATAOKA KAZUNORI·Filed 2012·Application pending·0 cites
- 2752US5756686APeptides derived from endothelial cell growth factorLUDWIG INST CANCER RES·Filed 1991·Granted May 26, 1998·11 cites·10 claims
- 2849US6632618B1Morphogenic protein-specific cell surface receptors and uses thereforCURIS INC·Filed 1995·Granted Oct 14, 2003·4 cites·6 claims
- 2949US2009186076A1Combined Use of TGF-Beta Signaling Inhibitor and Antitumor AgentKATAOKA KAZUNORI·Filed 2006·Application pending·0 cites
- 3048US2008131910A1Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their useMIYAZONO KOHEI·Filed 2007·Application pending·0 cites
- 3148US2023137306A1Viral infection therapeuticUNIV TOKYO·Filed 2021·Application pending·0 cites
- 3247US5177197AIsolated nucleotide sequence expressing human transforming growth factor-β1-binding proteinLUDWIG INST CANCER RES·Filed 1990·Granted Jan 5, 1993·10 cites·12 claims
- 3344US6270994B1Smad6 and uses thereofJAPAN FOUND CANCER·Filed 1998·Granted Aug 7, 2001·4 cites·15 claims
- 3429US2012039808A1Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain TumorMIYAZONO KOHEI·Filed 2011·Application pending·0 cites
- 3524US6030795ARecombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein productionLUDWIG INST CANCER RES·Filed 1996·Granted Feb 29, 2000·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Kohei Miyazono files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →